Lmr Partners LLP Matinas Bio Pharma Holdings, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $74,464 - $109,214	-99,286 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $95,314 - $172,757	99,286 New	99,286 $104,000
Q3 2018 Nov 14, 2018	SELL	$0.35 - $0.92 $69,667 - $183,126	-199,050 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$0.42 - $0.74 $83,601 - $147,297	199,050 New	199,050 $86,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $137M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.